Growth in the fertility test market can be attributed to factors such as the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and increased awareness of fertility testing in both developed as well as developing countries.
On the other hand, the unproven accuracy of urine-based ovulation monitors in women suffering from PCOS and the lesser precision to confirm ovulation using ovulation predictions kits are the factors that are expected to restrain market growth to a certain extent in the coming years.
The global fertility test market is expected to reach 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%.
Growth in the fertility test market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing.
Download PDF Brochure@
# In 2017, Swiss Precision Diagnostics (Switzerland) launched its Clearblue Connected Ovulation Test System.
# In 2017, NFI Consumer Healthcare (US) a division of Gregory Pharmaceutical Holdings (US) completed the acquisition of e.p.t over-the-counter pregnancy test kit brand from Prestige Brands Holdings.
# In 2017, Fairhaven Health (US), launched TempCue, a basal body temperature (BBT) thermometer.
# In 2016, Fertility Focus (UK) launched OvuSense App.
The ovulation predictor kits segment accounted for the largest share of the market by product in 2018
The fertility test market is segmented on the basis of product into ovulation predictor kits, fertility monitors, and male fertility testing products. The fertility monitors segment is further categorized into urine-based, saliva-based and other fertility monitors. The ovulation predictor kits segment commanded the largest share of the global fertility test market in 2018. This is primarily due to their high efficacy and low cost, high preference for these products, ease of use, low cost as compared to fertility monitors, and easy OTC availability.
Key Questions Addressed by the Report:
# What are the growth opportunities related to the adoption of fertility test products across major regions in the future?
# Emerging countries have immense opportunities for the growth and adoption of ovulation prediction kits. Will this scenario continue in the next five years?
# Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
# How will the increasing use of ovulation tracking mobile apps and fertility-tracking websites affect the growth of the market?
North America is expected to dominate the fertility test market during the forecast period.
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global fertility test market during the forecast period (2018-2023). The large share can be attributed to the growing use of fertility monitoring devices for contraception and rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites. In addition, the emergence of advanced easy-to-use fertility monitors with high accuracy is one of the key factors propelling the growth of the fertility test market in North America.
Request Sample Pages@
The major players operating in the fertility test market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings (US), among others.
Analysis of the market developments between 2015 and 2018 revealed that several growth strategies such as product launches, enhancements, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the fertility test market. Among these business strategies, product launches was the most widely adopted growth strategies by the players in the fertility test market.